ISIN | LU0953041174 |
---|---|
Valor Number | 21812702 |
Bloomberg Global ID | |
Fund Name | Europe Index -I dy EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the fund is to achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 248.73 EUR | 06.06.2025 |
---|---|---|
Previous Price * | 247.84 EUR | 05.06.2025 |
52 Week High * | 249.28 EUR | 03.03.2025 |
52 Week Low * | 208.74 EUR | 09.04.2025 |
NAV * | 248.73 EUR | 06.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,269,063,325 | |
Unit/Share Assets *** | 32,138,390 | |
Trading Information SIX |
YTD Performance | +11.17% |
31.12.2024 - 06.06.2025
31.12.2024 06.06.2025 |
---|---|---|
YTD Performance (in CHF) | +10.88% |
31.12.2024 - 06.06.2025
31.12.2024 06.06.2025 |
1 month | +3.98% |
06.05.2025 - 06.06.2025
06.05.2025 06.06.2025 |
3 months | +1.18% |
06.03.2025 - 06.06.2025
06.03.2025 06.06.2025 |
6 months | +5.67% |
06.12.2024 - 06.06.2025
06.12.2024 06.06.2025 |
1 year | +5.32% |
06.06.2024 - 06.06.2025
06.06.2024 06.06.2025 |
2 years | +19.56% |
06.06.2023 - 06.06.2025
06.06.2023 06.06.2025 |
3 years | +25.37% |
07.06.2022 - 06.06.2025
07.06.2022 06.06.2025 |
5 years | +50.63% |
08.06.2020 - 06.06.2025
08.06.2020 06.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.56% | |
---|---|---|
Nestle SA | 2.37% | |
ASML Holding NV | 2.20% | |
Roche Holding AG | 1.95% | |
Novartis AG Registered Shares | 1.90% | |
AstraZeneca PLC | 1.88% | |
Novo Nordisk AS Class B | 1.80% | |
HSBC Holdings PLC | 1.68% | |
Shell PLC | 1.67% | |
Siemens AG | 1.47% | |
Last data update | 30.04.2025 |
TER *** | 0.30% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.30% |
Ongoing Charges *** | 0.31% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |